PGP and neoplasm: Over-expression of p-glycoprotein (p-gp) or other drug transporter on DOX-resistant tumor cell resulted in the efflux of DOX from the tumor cells5, which reduce the accumulation of DOX in nucleus and decrease the antitumor efficacy of DOX, subsequently, lead to the recurrence of tumor6, 7.